NCT06265571

Brief Summary

After the approval of the ethics committee, the files of the patients who underwent arthroscopic shoulder surgery between 01.01.2019 and 01.03.2020 were evaluated retrospectively. Data were recorded including age, gender, duration of anesthesia, duration of surgery, postoperative analgesia consumption, complications such as respiratory distress due to hemidiaphragmatic paralysis and complications such as hematoma and nerve damage due to block intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 15, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2021

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

September 11, 2023

Completed
5 months until next milestone

First Posted

Study publicly available on registry

February 20, 2024

Completed
Last Updated

February 20, 2024

Status Verified

February 1, 2024

Enrollment Period

7 months

First QC Date

September 11, 2023

Last Update Submit

February 16, 2024

Conditions

Pain, Postoperative

Outcome Measures

Primary Outcomes (2)

  • rescue analgesia

    postoperative pain score (VAS) \> 4 required to rescue analgesia

    between 01.01.2019 and 01.03.2020

  • difference between the analgesic methods

    between 01.01.2019 and 01.03.2020

Study Arms (2)

GROUP I

Interscalene block (group I)15 ml of 0.5% bupivacaine was applied with a single injection to 12 of 18 patients,

Other: perineural injection

GROUP II

7.5 ml of interscalene and 7.5 ml of suprascapular block (GROUP II) were applied to 6 patients with posterior approach.

Other: perineural injection

Interventions

perineural injectionOTHER

perineural injection of local anesthestetic for postoperative pain management

GROUP IGROUP II

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

\>18 years old patients undergoing arthroscopic shoulder surgery by the same surgeon.

You may qualify if:

  • arthroscopic shoulder surgery full data form

You may not qualify if:

  • chronic obstructive lung disease chronic opoid consumption missing data from the postoperative pain form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ferda YAMAN

Eskişehir, Odunpazarı, 26040, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Ferda YAMAN, Assoc prof

    University of Eskişehir Osmangazi

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 11, 2023

First Posted

February 20, 2024

Study Start

November 15, 2020

Primary Completion

June 15, 2021

Study Completion

July 15, 2021

Last Updated

February 20, 2024

Record last verified: 2024-02

Locations

TU(1)